EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”) is effective as of April 1, 2021 (the “Effective Date”), by and between Kiniksa Pharmaceuticals Corp., a Delaware corporation (the “Company”), and Mark Ragosa (the “Employee”).
COMMERCIAL SUPPLY AGREEMENTCommercial Supply Agreement • May 6th, 2021 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations • New York
This Commercial Supply Agreement (including Exhibit 1 hereto, this “Agreement”) is entered into as of February 26, 2021 (the “Effective Date”) by and between:
AMENDMENT NO. 1License Agreement • May 6th, 2021 • Kiniksa Pharmaceuticals, Ltd. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (“Amendment No. 1”) to that certain License Agreement dated as of September 25, 2017 (the “Original Agreement”) by and between Kiniksa Pharmaceuticals, Ltd., a Bermuda exempted company and having an address at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (“Kiniksa”), and Regeneron Pharmaceuticals, Inc., a corporation organized under the laws of New York and having an address at 777 Old Saw Mill River Road, Tarrytown, New York 10591 (“Regeneron”) is effective as of October 29, 2020. Each of Regeneron and Kiniksa shall be referred to herein individually as a “Party” and collectively as the “Parties”. Unless otherwise defined herein, all capitalized terms shall have the meanings ascribed to them in the Original Agreement.
